Home » NUVASIVE LAUNCHES PERCUTANEOUS I-PAS INSULATED PEDICLE ACCESS SYSTEM
NUVASIVE LAUNCHES PERCUTANEOUS I-PAS INSULATED PEDICLE ACCESS SYSTEM
NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today the launch of the Insulated Pedicle Access System, or I-PAS(TM), a surgical instrument used to determine the safe percutaneous approach pathway of a pedicle screw prior to its implantation. I-PAS is designed to be used in conjunction with the Company's NeuroVision(R) nerve avoidance software to dynamically test the percutaneous approach of a pedicle screw prior to its implantation into the vertebral body.
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May